Mind Medicine (MNMD) Price Target Raised – Analysts See 700% Upside
Mind Medicine Inc. (NASDAQ:MNMD) commonly known as MindMed, is a clinical-stage biopharmaceutical company dedicated to developing psychedelic-inspired therapies…
Nutex Health (NUTX) Could Crash If Compliance Plan Fails
Nutex Health Inc. (NASDAQ:NUTX) is a physician-led, integrated healthcare delivery system that has quickly become one of the…
Corcept Therapeutics (CORT) Crashed Monday – Is This the Start of a Bigger Selloff?
Corcept Therapeutics Incorporated (NASDAQ:CORT) is a commercial-stage biopharmaceutical company that has built its reputation by focusing on the…
ARS Pharmaceuticals (SPRY)Reports $15.7M Q2 Revenue
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) is a biopharmaceutical company based in San Diego, California that has quickly risen as…
LifeVantage (LFVN) Faces Big Questions Despite Its Global Growth
LifeVantage Corporation (NASDAQ:LFVN) is a health and wellness company headquartered in Lehi, Utah, best known for its development…
Can Forward Industries (FORD) Turn Its 60-Year Legacy Into Market Gold?
Forward Industries Inc. (NASDAQ:FORD) is a global design, sourcing, and distribution company that has evolved over the decades…
Investors Are Betting Big on Palvella Therapeutics (PVLA)
Palvella Therapeutics, Inc. (NASDAQ:PVLA) is a clinical-stage biotechnology company dedicated to developing and commercializing innovative therapies for serious…
Zimmer Biomet (ZBH)’s 3% Gain Could Be a Trap for Investors
Zimmer Biomet Holdings Inc. (NYSE:ZBH) is one of the world’s leading medical technology companies, specializing in the design,…
Johnson & Johnson (JNJ) Is Trading Near Highs—But Analysts Warn of a Reality Check
Johnson & Johnson (NYSE:JNJ) is one of the most recognized and enduring names in global healthcare, with a…
Analysts Call Boston Scientific (BSX) a “Forever Company” for Investors
Boston Scientific Corporation (NYSE:BSX) is one of the world’s leading medical technology innovators, recognized globally for its commitment…
Cidara (CDTX)’s $400 Million Raise: Lifeline or Investor Trap?
Cidara Therapeutics Inc. (NASDAQ:CDTX) is a biotechnology company headquartered in San Diego, California, that has built its identity…
Jazz Pharmaceuticals (JAZZ)’s Latest Deal Could Make—or Break—Its Entire Future
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) is a global biopharmaceutical company headquartered in Dublin, Ireland, and listed on the NASDAQ…
Will LYTENAVA Make History? Outlook Therapeutics (OTLK)’s Big FDA Moment Approaches
Outlook Therapeutics Inc. (NASDAQ:OTLK) is an innovative biopharmaceutical company dedicated to developing and commercializing transformative therapies for ophthalmic…
Elicio Therapeutics (ELTX): The Cancer Vaccine Revolution Changing Lives in 2025
Elicio Therapeutics, Inc. (NASDAQ:ELTX) is a clinical-stage biotechnology company pioneering the development of novel immunotherapies to combat some…
Cyclerion Therapeutics (CYCN) Poised for Massive Growth with $1.75M License Deal
Cyclerion Therapeutics Inc. (NASDAQ:CYCN) is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts, dedicated to the discovery and…
Propanc Biopharma (PPCB) Raises $4M: Is This the Hidden Gem of Oncology?
Propanc Biopharma, Inc. (NASDAQ:PPCB) is an innovative biopharmaceutical company dedicated to developing breakthrough cancer therapies for patients battling…
Schizophrenia Breakthrough Alert: Minerva Neurosciences (NERV)’s Roluperidone Gains FDA Attention
Minerva Neurosciences Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company listed on Nasdaq under the ticker NERV, is at the…
Saudi Arabia Deal Could Catapult CEL-SCI (CVM) Into Global Biotech Spotlight
CEL-SCI Corporation (NYSE:CVM) is a pioneering biotechnology company headquartered in Vienna, Virginia, with additional operations near Baltimore, Maryland.…